Authors: Moreau, A Lacroix-Desmazes, S Stieltjes, N Saenko, E Kaveri, SV D'Oiron, R Sultan, Y Scandella, D Kazatchkine, MD

Citation: A. Moreau et al., Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophiliaA and in normal polyclonal human IgG, BLOOD, 95(11), 2000, pp. 3435-3441

Authors: Batlle, J Lopez, MF Brackmann, HH Gaillard, S Goudemand, J Humbert, J De Moerloose, P Maass, E Mauz-Korholz, C Sultan, Y Stieltjes, N

Citation: J. Batlle et al., Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors, HAEMOPHILIA, 5(6), 1999, pp. 431-435

Authors: Molho, P Verrier, P Stieltjes, N Schacher, JM Ounnoughene, N Vassilieff, D Menkes, CJ Sultan, Y

Citation: P. Molho et al., A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis, HAEMOPHILIA, 5(2), 1999, pp. 115-123

Authors: Lacroix-Desmazes, S Moreau, A",Sooryanarayana,"Bonnemain, C Stieltjes, N Pashov, A Sultan, Y Hoebeke, J Kazatchkine, MD Kaveri, SV

Citation: S. Lacroix-desmazes et al., Catalytic activity of antibodies against factor VIII in patients with hemophilia A, NAT MED, 5(9), 1999, pp. 1044-1047

Authors: Blanche, P Bouscary, D Gombert, B Stieltjes, N Dreyfus, F Sicard, D

Citation: P. Blanche et al., Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia, LEUKEMIA, 13(8), 1999, pp. 1294-1294